Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Daily News

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

L.A. McKeown

January 06, 2025

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Conference News CRT 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

L.A. McKeown

February 27, 2020

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

April 26, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

News Daily News

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Shelley Wood

March 06, 2017

News Daily News

Desarrollan una Calculadora para Predecir el Riesgo de LRA Post-Angiografía en una Población de Veteranos

Caitlin E. Cox

December 29, 2015

News Daily News

Calculator Developed to Predict AKI Risk After Angiography in VA Population

Caitlin E. Cox

December 29, 2015

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Daily News

Una Prueba No Invasiva asocia el Volumen de Fluido Pre-Angiografía a Futuros Daños Renales

Caitlin E. Cox

February 12, 2014

Advertisement

Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

September 2024 Dispatch for the CV Team

Kidney Events High in Older Patients After HF Hospitalization

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

November 2021 News Roundup

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Renal Function Gains Seen in CKD Patients After TAVR

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

No IV Hydration for Contrast Nephropathy? AMACING Trial Challenges a Cornerstone of Prophylaxis

Desarrollan una Calculadora para Predecir el Riesgo de LRA Post-Angiografía en una Población de Veteranos

Calculator Developed to Predict AKI Risk After Angiography in VA Population

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

Una Prueba No Invasiva asocia el Volumen de Fluido Pre-Angiografía a Futuros Daños Renales

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content